Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

International journal of radiation oncology, biology, physics - 1 Apr 2008

Spry Nigel, Harvey Jennifer, Macleod Craig, Borg Martin, Ngan Samuel Y, Millar Jeremy L, Graham Peter, Zissiadis Yvonne, Kneebone Andrew, Carroll Susan, Davies Terri, Reece William H H, Iacopetta Barry, Goldstein David

Abstract excerpt

PURPOSE: The aim of this Phase II study was to examine whether concurrent continuous infusion 5-fluorouracil (CI 5FU) plus three-dimensional conformal planning radiotherapy sandwiched between gemcitabine chemotherapy is effective, tolerable, and safe in the management of pancreatic cancer. METHODS AND MATERIALS: Patients were enrolled in two strata: (1) resected pancreatic cancer at high risk of local relapse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-19-9 Antigen
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deoxycytidine

Share to Drug Administration Schedule

Share to Fluorouracil

Share to Gemcitabine

Share to Neoplasm Recurrence, Local

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 18164859
DOI: 10.1016/j.ijrobp.2007.08.070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.PMID 18164859Read ↗

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.Semantic proximity Read ↗

Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.Semantic proximity Read ↗

Durable Response of Induction Sequential Chemotherapy Combined With Nimotuzumab and Consolidative Carbon Ion Radiotherapy With Non-V600 BRAF Mutation Locally Advanced Pancreatic CancerSemantic proximity Read ↗

A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.Semantic proximity Read ↗

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.Semantic proximity Read ↗

Pancreatic cancer: what the oncologist can offer for palliation.Semantic proximity Read ↗

Weekly paclitaxel as a radiation sensitizer for locally advanced gastric and pancreatic cancers: the Brown University Oncology Group experience.Semantic proximity Read ↗

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.Semantic proximity Read ↗

Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.